Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal sleep aid shows promise in midlife insomnia trial

NCT ID NCT07461402

Symptom relief Sponsor: Universidad Pablo de Olavide Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a daily mix of plant protein and two herbs (ashwagandha and rhodiola) could improve sleep in 100 adults aged 35-70 with sleep troubles. Participants took either the supplement or a placebo for 30 days and reported their sleep quality daily. The goal was to see if the supplement leads to better sleep and overall cellular health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Nov 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 35 to 70 years (inclusive) * Experiencing sleep disturbances or sleep quality problems * Willing and able to consume plant protein supplement daily for 30 days * Willing and able to take adaptogen tablets daily for 30 days * Able to provide written informed consent * Able to complete daily sleep quality questionnaires * Available for baseline and follow-up assessments * Willing to maintain regular lifestyle habits during the study period Exclusion Criteria: * Age less than 35 years or greater than 70 years * Known allergies or hypersensitivity to any study ingredients (pea protein, rice protein, hemp protein, Rhodiola rosea, Withania somnifera/ashwagandha, or excipients) * Current use of prescription sleep medications or hypnotics * Current use of other herbal supplements for sleep (washout period may be allowed) * Serious or unstable medical conditions that could interfere with study participation or safety * Severe psychiatric disorders requiring medication * Uncontrolled metabolic diseases (for example, uncontrolled diabetes, thyroid disorders) * Pregnancy or lactation * Planning to become pregnant during the study period * Participation in another clinical trial within the past 30 days * Inability to understand or comply with study procedures * Shift workers or individuals with irregular sleep schedules * Recent major life events significantly affecting sleep patterns

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia sleep disorder sleep-wake disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insomnia Sleep disorders Sleep quality

Contacts and locations

Locations

  • Farmacia Molina

    Seville, Cordoba, 14400, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.